Home » Topics » Regulatory

Regulatory
RSS

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

FDA approves Palynziq for adults with phenylketonuria

May 25, 2018

Prolia approved in U.S. for glucocorticoid-induced osteoporosis

May 22, 2018

FDA approves thrombopoietin receptor agonist Doptelet

May 22, 2018

FDA approves Aimovig for prevention of migraine

May 18, 2018

FDA approves Briviact oral formulations for the treatment of pediatric patients

May 15, 2018

FDA approves Gilenya to treat MS in pediatric patients

May 14, 2018